DCB-PCI: What you need to know

2 Views
Published
In this video interview, Cardiovascular News sits down with Bernardo Cortese (Harringhton Heart & Vascular Institute UH, Cleveland, USA) to tackle the latest advancements and challenges surrounding the use of drug-coated balloons (DCBs) in percutaneous coronary intervention (PCI).

Cortese explores the contemporary issues impacting the adoption of DCB-PCI in clinical practice, highlights the latest evidence on patient selection, the role of DCBs in various lesion subsets, and the importance of data in shaping guidelines and treatment protocols.

He also touches on the work of the DCB Academy, an educational instutution designed to advance the understanding and clinical application of DCBs in interventional cardiology, strictly linked to the research activity of Fondazione RIC (www.fondazioneric.org).
Category
Cardiology
Be the first to comment